20 January 2021 2 Min Read
Distell and Invenfin move into cannabis
The two companies paid undisclosed amounts to each buy a 20% stake in Releaf Pharmaceuticals
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In